European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis. - Comi,G.; Filippi,M.; Wolinsky,J.S. (Ann Neurol, 2001)